J. Robles

Preoperative low-dose weekly cisplatin and continuous infusion fluorouracil plus hyperfractionated radiotherapy in stage II–III esophageal carcinoma

E. Musulen, A. Font, J. Remon, 2016, Clinical and Translational Oncology.

18F-FDG PET/CT in the evaluation of patients suspected of paraneoplastic neurological syndrome

A. M. G. Vicente, Á. Castrejón, G. A. J. Londoño, 2015 .

Multidisciplinary cancer care may impact on the postoperative mortality and survival of patients with oesophageal and oesophagogastric junction cancer: a retrospective cohort study

J. Borrás, L. Aliste, R. Mast, 2015, Clinical and Translational Oncology.

18F-FDG PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-Positive Breast Cancer: Results from Neo-ALTTO

Eileen Holmes, Patrick Flamen, Camilo Garcia, 2013, The Journal of Nuclear Medicine.

5013 ORAL FDG-PET/CT for Early Prediction of Response to Neoadjuvant Lapatinib, Trastuzumab, and Their Combination in HER2-positive Breast Cancer Patients: the Neo-ALTTO Study Results

J. Baselga, S. Cosimo, M. Piccart-Gebhart, 2011 .

Clinical relevance of histologic subtypes in locally advanced esophageal carcinoma treated with pre-operative chemoradiotherapy: Experience of a monographic oncologic centre

L. Aliste, N. Sala, M. Saigí, 2017, PloS one.

Differences on metabolic behavior between intra and extrahepatic cholangiocarcinomas at 18F-FDG–PET/CT: prognostic implication of metabolic parameters and tumor markers

G. Reynés-Llompart, C. Gámez-Cenzano, T. Serrano, 2018, Clinical and Translational Oncology.